Omega-3 fatty acids used to treat patients with dysglycemia in the ORIGIN trial failed to reduce cardiovascular death or ischemic events. Follow-up was 6 years.
Deepak L. Bhatt, MD
Advertisement
Articles by Deepak L. Bhatt, MD
Advertisement
Latest Updated Articles
Omega-3 Fatty Acid Therapy: What Comes Next?Published: August 22nd 2012 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
New Menopause Survey Finds Energy Loss, Poor Sleep, and Seasonal Symptoms Most Disruptive
2
The Adult Immunization Catch-Up Schedule: A Practical Guide for Primary Care
3
Undertreated Acute Pain Poses Long-Term Risks, But Prescription Opioids Still Do, Too ...
4
Diagnosing DVT: Clinical Pearls for Challenging Presentations
5
